In line with previous studies, our current research found that CXCL10 activates pro-angiogenic and pro-growth signals, such as ERK, AKT, JAK2, and CREB, potentially mediated by CXCR3-A, which lead to increased B16F10 tumor growth and angiogenesis. The gene discussed is CXCL10; the disease is neoplasm.